Search results

Selected filters:

Life Sciences
Analysis

Article type

Topic

Sector

Regions

Year

205 results found for your search

Sort options
20 June 2019

Another year, another benchmarking survey and the EPO is top once more

Boost for António Campinos as he ends the first year of his presidency; and good news, too, for USPTO head Andrei Iancu

18 June 2019

Pfizer’s $11 billion Array purchase shows oncology assets continue to drive pharma transactions

The world’s largest life sciences company demonstrates that it is still a major presence in the M&A landscape, despite its stated focus on organic growth.

14 June 2019

$100,000 for a patent? Not all are convinced, but many admit the price tag should rise

In an interview with IAM Rembrandts in the Attic author Kevin Rivette made the case for applicants spending a lot more on the prosecution process. We asked the market whether it agreed.

13 June 2019

Three questions that require answers before we get a patent eligibility bill

Section 101 hearings end with Senator Tillis admitting that work needs to be done on key parts of the proposal; says to expect draft legislation after 4th July break

11 June 2019

University seizes on Supreme Court ruling to breathe new life into PTAB sovereign immunity arguments

In Return Mail SCOTUS rules that government cannot bring post issuance patent challenges; lawyers for University of Minnesota claim that decision supports their case currently before the CAFC

11 June 2019

Taiwan Semiconductor spins patents to gene sequencing leader

Transfer of microfluidics tech comes as San Diego-based Illumina faces a fierce IP fight with an upstart Chinese rival

07 June 2019

Roche trumps rivals with strongest biotech patent portfolio

Trailing behind the Swiss giant are DowDuPont and Bayer, both of which have seen a drop in the value of their holdings

07 June 2019

China overhauls criminal IP enforcement

Food and drug authorities will take responsibility for criminal IP investigations, as government re-shuffle continues. It’s good news for pharma IP owners – others may have questions

06 June 2019

Unprecedented Congressional engagement on patent eligibility reform, but don't bet on a rush to legislation

All the key takeaways from six panels and 30 witnesses across two days of hearings which highlighted the progress made and big challenges ahead as US senators put the focus on section 101 

04 June 2019

India makes concessions to high tech on patent ‘working’

The Patent Office has proposed simplifications to Form 27, which plays a role in compulsory licensing and injunctions, after complaints by Ericsson, Nokia, Huawei and others

04 June 2019

IP3 deals platform makes key rule change to drum up more seller interest

Patent owners will not be required to take assets off the market after making submissions; this year's programme also features new sector focus areas

30 May 2019

$1 billion Keytruda deal illustrates value of royalty right sales for research institutes

Transformative agreement shows why niche investment model may appeal to cash-strapped life sciences innovators

28 May 2019

US biotech aims to curb China’s genomics leader with pair of European lawsuits

Shenzhen BGI was once the biggest purchaser of Illumina’s gene sequencing machines. Now the two are on opposite sides of an expanding patent battle

24 May 2019

Business, but not as usual

Our week-long series on the US-China trade dispute concludes, as deal-makers working on the ground say licence transactions and tech transfer are still happening, but big uncertainties remain

24 May 2019

New subject matter draft bill adds momentum to US patent eligibility reform movement

Proposals seen as way of limiting overly broad grants while also reducing 101’s impact; legislators tee-up series of marathon public hearings for the summer